229
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association Between Elevated Thyroid Peroxidase Antibody and Abdominal Fat Distribution in Patients with Type 2 Diabetes Mellitus

ORCID Icon, , , & ORCID Icon
Pages 863-871 | Published online: 17 Mar 2022

References

  • Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev. 2018;39(2):79–132. doi:10.1210/er.2017-00253
  • Fang L, Guo F, Zhou L, Stahl R, Grams J. The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans. Adipocyte. 2015;4(4):273–279. doi:10.1080/21623945.2015.1034920
  • González N, Moreno-Villegas Z, González-Bris A, Egido J, Lorenzo Ó. Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):44. doi:10.1186/s12933-017-0528-4
  • Huang JW, Yang CY, Wu HY, Liu KL, Hung KY. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients. Cardiovasc Diabetol. 2013;12(1):86. doi:10.1186/1475-2840-12-86
  • Ruiz HH, Díez RL, Arivazahagan L, Ramasamy R, Schmidt AM. Metabolism, obesity, and diabetes mellitus. Arterioscler Thromb Vasc Biol. 2019;39(7):e166–e174. doi:10.1161/ATVBAHA.119.312005
  • Chistiakov DA. Immunogenetics of Hashimoto’s thyroiditis. J Autoimmune Dis. 2005;2(1):1–21. doi:10.1186/1740-2557-2-1
  • García-Solís P, García OP, Hernández-Puga G, et al. Thyroid hormones and obesity: a known but poorly understood relationship. Endokrynol Pol. 2018;69(3):292–303. doi:10.5603/EP.2018.0032
  • Chang YC, Hua SC, Chang C-H. High TSH level within normal range is associated with obesity, dyslipidemia, hypertension, inflammation, hypercoagulability, and the metabolic syndrome: a novel cardiometabolic marker. J Clin Med. 2019;8(6):817. doi:10.3390/jcm8060817
  • Chen Y, Chen Y, Wang N, et al. Thyroid stimulating hormone within the reference range is associated with visceral adiposity index and lipid accumulation product: a population-based study of SPECT-China. Horm Metab Res. 2018;50(1):29–36. doi:10.1055/s-0043-122235
  • Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293. doi:10.1089/10507250252949405
  • Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol. 2005;62(4):487–491. doi:10.1111/j.1365-2265.2005.02247.x
  • Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, Berrington de González A. Body fatness and markers of thyroid function among U.S. men and women. PLoS One. 2012;7(4):e34979. doi:10.1371/journal.pone.0034979
  • Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181–186. doi:10.1530/eje.1.02333
  • De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol. 2007;67(2):265–269. doi:10.1111/j.1365-2265.2007.02874.x
  • Pearce EN. Thyroid hormone and obesity. Curr Opin Endocrinol Diabetes Obes. 2012;19(5):408–413. doi:10.1097/MED.0b013e328355cd6c
  • Ren R, Jiang X, Zhang X, et al. Association between thyroid hormones and body fat in euthyroid subjects. Clin Endocrinol. 2014;80(4):585–590. doi:10.1111/cen.12311
  • Roef GL, Rietzschel ER, Van Daele CM, et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid. 2014;24(2):223–231. doi:10.1089/thy.2013.0314
  • Tamer G, Mert M, Tamer I, Mesci B, Kilic D, Arik S. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol. 2011;62(5):421–428.
  • Dosi RV, Tandon N. A study on prevalence of thyroid auto-immunity in type 1 diabetes mellitus. J Indian Med Assoc. 2010;108(6):349–350, 355–346.
  • Shun CB, Donaghue KC, Phelan H, Twigg SM, Craig ME. Thyroid autoimmunity in Type 1 diabetes: systematic review and meta-analysis. Diabet Med. 2014;31(2):126–135. doi:10.1111/dme.12318
  • Elebrashy IN, El Meligi A, Rashed L, Salam RF, Youssef E, Fathy SA. Thyroid dysfunction among type 2 diabetic female Egyptian subjects. Ther Clin Risk Manag. 2016;12:1757–1762.
  • Sarfo-Kantanka O, Sarfo FS, Ansah EO, et al. Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study. BMC Endocr Disord. 2017;17(1):2. doi:10.1186/s12902-016-0152-4
  • Chen Y, Wang N, Chen Y, et al. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: a new insight from SPECT-China study. Autoimmunity. 2018;51(5):238–244. doi:10.1080/08916934.2018.1488968
  • Wang C, Niu Q, Lv H. Elevated TPOAb is a strong predictor of autoimmune development in patients of type 2 diabetes mellitus and non-alcoholic fatty liver disease: a case-control study. Diabetes Metab Syndr Obes. 2020;13:4369–4378. doi:10.2147/DMSO.S280231
  • Sotak S, Felsoci M, Lazurova I. Type 2 diabetes mellitus and thyroid disease: a two-sided analysis. Bratisl Lek Listy. 2018;119(6):361–365. doi:10.4149/BLL_2018_067
  • American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S37–S47. doi:10.2337/dc20-S004
  • Song RH, Wang B, Yao QM, Li Q, Jia X, Zhang JA. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front Immunol. 2019;10:2349. doi:10.3389/fimmu.2019.02349
  • Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J Clin Endocrinol Metab. 2016;101(2):669–677. doi:10.1210/jc.2015-3235
  • Mousa U, Bozkuş Y, Kut A, Demir CC, Tutuncu NB. Fat distribution and metabolic profile in subjects with Hashimoto’s thyroiditis. Acta Endocrinol. 2018;14(1):105–112. doi:10.4183/aeb.2018.105
  • Lu S, Guan Q, Liu Y, et al. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis. 2012;11:17. doi:10.1186/1476-511X-11-17
  • Fröhlich E, Wahl R. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. doi:10.3389/fimmu.2017.00521
  • Ruggeri RM, Vicchio TM, Cristani M, et al. Oxidative stress and advanced glycation end products in Hashimoto’s thyroiditis. Thyroid. 2016;26(4):504–511. doi:10.1089/thy.2015.0592
  • Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41(4):810–817. doi:10.1093/ajcn/41.4.810
  • Park KS, Lee DH, Lee J, et al. Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. 2016;30(2):343–349. doi:10.1016/j.jdiacomp.2015.10.014
  • Yuji M. New criteria for “obesity disease” in Japan: the examination committee of criteria for ‘obesity disease’in Japan, Japan society for the study of obesity. New criteria for ‘obesity disease’in Japan. Circ J. 2002;66(11):987–992. doi:10.1253/circj.66.987